Need professional-grade analysis? Visit stockanalysis.com
$40.14B
N/A
1,254
N/A
Hebei Changshan Biochem Pharma (300255) trades on SHE in CNY. The company is classified in the Healthcare sector under the Biotechnology industry. The stock currently trades at CNY43.67, down 2.63% from the previous close.
Over the past year, 300255 has traded between a low of CNY20.49 and a high of CNY69.80. The stock has gained 113.1% over this period. It is currently 37.4% below its 52-week high.
Hebei Changshan Biochem Pharma has a market capitalization of $40.14B.
Hebei Changshan Biochemical Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of crude heparin, heparin raw materials, and heparin preparations for the treatment of cardiovascular and cerebrovascular diseases in China and internationally. The company offers crude heparin sodium, heparin sodium API, heparin sodium injections, low molecular weight heparin calcium injections, enoxaparin sodium injections, nandroparin calcium injection, dalteparin sodium API and injections, and other products. The company was founded in 2000 and is headquartered in Shijiazhuang, China.
Side-by-side comparison against top Healthcare peers.